BioCentury
ARTICLE | Company News

BioTime management update

May 6, 2013 7:00 AM UTC

BioTime Inc. (NYSE-M:BTX), Alameda, Calif. Business: Gene/Cell therapy, Pulmonary, Diagnostic Transitioning: Robert Peabody to CFO, effective May 10, while remaining SVP and COO; he replaces Peter Gar...